Ardelyx
ARDX
#5374
Rank
โ‚น144.02 B
Marketcap
โ‚น583.05
Share price
-3.78%
Change (1 day)
72.46%
Change (1 year)

Revenue for Ardelyx (ARDX)

Revenue in 2026 (TTM): โ‚น38.24 Billion

According to Ardelyx's latest financial reports the company's current revenue (TTM ) is โ‚น40.81 Billion. In 2025 the company made a revenue of โ‚น36.56 Billion an increase over the revenue in the year 2024 that were of โ‚น28.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ardelyx from 2013 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น38.24 B4.59%
2025 โ‚น36.56 B27.76%
2024 โ‚น28.61 B176.23%
2023 โ‚น10.36 B140.05%
2022 โ‚น4.31 B474.3%
2021 โ‚น0.75 B35.73%
2020 โ‚น0.55 B47.03%
2019 โ‚น0.37 B106.59%
2018 โ‚น0.18 B-93.2%
2017 โ‚น2.68 B
2016 N/A-100%
2015 โ‚น1.59 B-20.34%
2014 โ‚น2.00 B12.15%
2013 โ‚น1.78 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Abbott Laboratories
ABT
โ‚น4.306 T 10,453.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.551 T 8,602.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น5.292 T 12,867.96%๐Ÿ‡ซ๐Ÿ‡ท France
AstraZeneca
AZN
โ‚น5.767 T 14,031.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
OPKO Health
OPK
โ‚น61.26 B 50.13%๐Ÿ‡บ๐Ÿ‡ธ USA